281208-98-8

Basic information

• Product Name: 2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE
• Synonyms: 2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE;AKOS AU36-M574;ASISCHEM D48942;2-CHLORO-6-ETHOXY-3-QUINOLINECARBOXALDEHYDE;2-CHLORO-6-ETHOXYQUINOLINE-3-CARBOXALDEHYDE;3-QUINOLINECARBOXALDEHYDE, 2-CHLORO-6-ETHOXY-;AKOS A1107-0007;OTAVA-BB 7118340023
• CAS NO: 281208-98-8
• Molecular Formula: C12H10ClNO2
• Molecular Weight: 235.67
• Mol File: 281208-98-8.mol

Chemical Properties

• Boiling Point: 384°C at 760 mmHg
• Flash Point: 186°C
• Appearance: /
• Density: 1.302g/cm³
• Vapor Pressure: 4.23E-06mmHg at 25°C
• Refractive Index: 1.639
• CAS DataBase Reference: 2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE(281208-98-8)
• EPA Substance Registry System: 2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE(281208-98-8)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 281208-98-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
2-Chloro-6-(ethyloxy)quinoline-3-carbaldehyde is utilized as a key building block in the development of pharmaceuticals. Its unique structure allows for the creation of novel compounds with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, 2-chloro-6-(ethyloxy)quinoline-3-carbaldehyde serves as an essential intermediate for the synthesis of new compounds designed to protect crops from pests and diseases.
Used as an Antimicrobial Agent:
2-Chloro-6-(ethyloxy)quinoline-3-carbaldehyde has been studied for its potential as an antimicrobial agent, indicating its use in combating various types of bacteria and other microorganisms.
Used as an Antiviral Agent:
2-CHLORO-6-(ETHYLOXY)QUINOLINE-3-CARBALDEHYDE is also being explored for its antiviral properties, suggesting its potential use in the development of treatments for viral infections.
Used in the Synthesis of Functionalized Quinoline Derivatives:
Due to its reactivity and structural features, 2-chloro-6-(ethyloxy)quinoline-3-carbaldehyde is employed as an intermediate in the synthesis of a range of functionalized quinoline derivatives, which can have diverse applications in various fields.

InChI:InChI=1/C12H10ClNO2/c1-2-16-10-3-4-11-8(6-10)5-9(7-15)12(13)14-11/h3-7H,2H2,1H3

Upstream product

• 62-44-2 4-ethoxyacetanilide 
• 68-12-2 N,N-dimethyl-formamide 
• 74-96-4 ethyl bromide 
• 741705-20-4 2-chloro-6-hydroxyquinoline-3-carbaldehyde 
• 73568-29-3 2-chloro-6-methoxyquinolin-3-carboxaldehyde 

Downstream Products

• 333408-52-9 3-(hydroxymethyl)-2-chloro-6-ethoxyquinoline 
• 485334-90-5 C₁₂H₁₀N₂O₂ 
• 1591873-25-4 C₃₅H₂₉ClN₂O₅ 
• 1591873-39-0 C₃₂H₃₀N₂O₅ 

Relevant articles and documents

Novel hydrazide-hydrazone and amide substituted coumarin derivatives: Synthesis, cytotoxicity screening, microarray, radiolabeling and in vivo pharmacokinetic studies

The current work presents the synthesis and biological evaluation of new series of coumarin hydrazide-hydrazone derivatives that showed in vitro broad spectrum antitumor activities against resistant pancreatic carcinoma (Panc-1), hepatocellular carcinoma (HepG2) and leukemia (CCRF) cell lines using doxorubicin as reference standard. Bromocoumarin hydrazide-hydrazone derivative (BCHHD) 11b showed excellent anticancer activity against all tested cancer cell lines. Enzyme assays showed that BCHHD 11b induced apoptosis due to activation of caspases 3/7. Moreover, 11b inhibited GST and CYP3A4 in a dose dependent manner and the induced cell death could be attributed to metabolic inhibition. Moreover, 11b microarray analysis showed significant up- and down-regulation of many genes in the treated cells related to apoptosis, cell cycle, tumor growth and suppressor genes. All of the above presents BCHHD 11b as a potent anticancer agent able to overcome drug resistance. In addition, compound 11b was able to serve as a chemical carrier for 99mTc and the in vivo biodistribution study of 99mTc-11b complex revealed a remarkable targeting ability of 99mTc into solid tumor showing that 99mTc-11b might be used as a promising radiopharmaceutical imaging agent for cancer.

SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A)

The invention relates to compounds of the formula wherein R′, R1, through R7 and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.

Synthesis of New dihydropyrimidinones catalysed by dicationic ionic Liquid

A convenient multi step synthetic protocol for new dihydropyrimidinones bearing quinolynyl methoxy phenyl moiety has been developed from 2-chloro-3-formyl quinolines. The last step is one-pot Biginelli reaction of multicomponents, 4-((2-chloroquinolin-3-yl) methoxy) benzaldehydes, ethyl acetoacetate and urea mediated and catalysed by dicationic ionic liquid (3-methyl-1-[3-(methyl-1H-imidazolium-1-yl) propyl]- 1H-imidazolium dibromide (C3 [min]2 2 [Br-] )). Simple work-up procedures and moderate to good yields of the pyrimidinones and the intermediates are the merits of the route. Indian Academy of Sciences.

NON-PEPTIDE GLP-1 AGONISTS

Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an ac

NOVEL 2-SUBSTITUTED CYCLIC AMINES AS CALCIUM SENSING RECEPTOR MODULATORS

The present invention relates to modulators of the calcium sensing receptor having the formula I (I) wherein Ar, X, n, R, R, R, and Q are as defined herein.